Wall Street Analysts See a 48.36% Upside in Arcutis Biotherapeutics (ARQT): Can the Stock Really Move This High?
Portfolio Pulse from
Wall Street analysts predict a 48.36% upside for Arcutis Biotherapeutics (ARQT) based on average price targets. Positive earnings estimate revisions could support this potential increase.
March 05, 2025 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wall Street analysts have set an average price target for Arcutis Biotherapeutics (ARQT) indicating a potential 48.36% upside. Positive earnings estimate revisions could support this potential increase.
The article highlights a significant potential upside for ARQT based on analysts' price targets. The positive trend in earnings estimate revisions adds credibility to this potential increase, suggesting a likely positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100